Osmolality and pH of anti-asthmatic drug solutions
- PMID: 2150739
- DOI: 10.1007/BF01997612
Osmolality and pH of anti-asthmatic drug solutions
Abstract
Mixtures of different drugs are frequently used in aerosol solution for treatment of asthma. These drugs have different pH and osmolality values as stock solutions. It has been suggested that acidity and osmolality interact in provoking bronchoconstriction and cough. Therefore, pH and osmolality of anti-asthmatic drug solutions and mixtures were measured in the nebulizer at 0, 1, 2, 5, 10 and 15 minutes of nebulisation, pH of fenoterol, ipratropium bromide, salbutamol and disodium cromoglycate ranged between 2.0 and 5.7 and did not change during nebulisation. Nearly all drug solutions were hypoosmolar and the osmolality increased during nebulisation with 11 to 62%. Therefore, it is suggested to dilute these drugs with saline 0.9% and to restrict nebulisation time to 10 minutes, since the most striking increase of osmolality was noted after 10 minutes.
Similar articles
-
[Osmolarity of solutions used in nebulization].Rev Mal Respir. 1998 Apr;15(2):191-5. Rev Mal Respir. 1998. PMID: 9608990 French.
-
Osmolality changes in nebulizer solutions.Eur Respir J. 1989 Oct;2(9):887-92. Eur Respir J. 1989. PMID: 2572453
-
Compatibility and aerosol characteristics of formoterol fumarate mixed with other nebulizing solutions.Ann Pharmacother. 2008 Oct;42(10):1416-24. doi: 10.1345/aph.1L273. Ann Pharmacother. 2008. PMID: 18780805
-
Compatibility of nebulizer solution admixtures.Ann Pharmacother. 1997 Apr;31(4):487-9. doi: 10.1177/106002809703100416. Ann Pharmacother. 1997. PMID: 9101012 Review. No abstract available.
-
Inhalation solutions: which one are allowed to be mixed? Physico-chemical compatibility of drug solutions in nebulizers.J Cyst Fibros. 2006 Dec;5(4):205-13. doi: 10.1016/j.jcf.2006.03.007. Epub 2006 May 5. J Cyst Fibros. 2006. PMID: 16678502 Review.
Cited by
-
Aerosolised antibacterials for the prevention and treatment of hospital-acquired pneumonia.Drugs. 2007;67(6):903-14. doi: 10.2165/00003495-200767060-00006. Drugs. 2007. PMID: 17428107 Review.
-
Nebulised Isotonic Hydroxychloroquine Aerosols for Potential Treatment of COVID-19.Pharmaceutics. 2021 Aug 14;13(8):1260. doi: 10.3390/pharmaceutics13081260. Pharmaceutics. 2021. PMID: 34452220 Free PMC article.
-
Compatible Stability and Aerosol Characteristics of Atrovent® (Ipratropium Bromide) Mixed with Salbutamol Sulfate, Terbutaline Sulfate, Budesonide, and Acetylcysteine.Pharmaceutics. 2020 Aug 15;12(8):776. doi: 10.3390/pharmaceutics12080776. Pharmaceutics. 2020. PMID: 32824123 Free PMC article.
-
Metered dose inhaler and nebuliser in acute asthma.Arch Dis Child. 1995 Mar;72(3):214-8. doi: 10.1136/adc.72.3.214. Arch Dis Child. 1995. PMID: 7741566 Free PMC article. Clinical Trial.
-
Respiratory Delivery of Lacticaseibacillus rhamnosus GG by Vibrating-Mesh and Jet Nebulisation.Pharmaceutics. 2024 Oct 14;16(10):1326. doi: 10.3390/pharmaceutics16101326. Pharmaceutics. 2024. PMID: 39458655 Free PMC article.